FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to chemical-pharmaceutical industry, medicine and veterinary science, and describes a composition with 2-ethyl-6-methyl-3-hydroxypyridine succinate for oral administration in the form of a tablet containing substantially 2-ethyl-6-methyl-3-hydroxypyridine succinate as an active ingredient and excipients: lactose monohydrate, sodium carboxymethyl cellulose and/or kollidon 30, magnesium stearate, opadry white. The invention can be used in medicine or veterinary science as the drug preparation 2-ethyl-6-methyl-3-hydroxypyridine succinate for oral administration for the purpose of treating and preventing various diseases and pathological conditions of an human or animal body.
EFFECT: composition is characterised by high bioavailability, three-year stability, minimum excipient content.
2 cl, 5 ex, 1 tbl
